19 August 2026
The AIDS drug tender dispute deepens as the Health Department defends its R15.5bn HIV procurement process ahead of a September court hearing.
28 July 2026
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
25 June 2026
Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.
21 February 2026
Delve into the AIDS Drug Tender Controversy where Motsoaledi points to the DG in the R15.5bn ARV procurement scandal.
9 February 2026
23 January 2026
The AIDS drug tender reveals challenges in supply continuity due to Avacare subsidiaries entering business rescue.
19 November 2025
Hetero SA challenges the HIV drug tender decision in court, claiming exclusion from vital antiretroviral supply contracts.
12 November 2025
The UK cuts contribution to the Global Fund by 15%, reducing support for critical health initiatives amid budget challenges.
5 November 2025
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
16 October 2025
Understand how African philanthropists can lead the way in health improvement efforts, saving lives and supporting innovation.
30 September 2025
Activists warn that the UNAIDS closure will critically affect HIV/AIDS progress, calling for urgent global health action.
29 September 2025
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.